apricus wealth LLC Purchases Shares of 2,540 Colgate-Palmolive (NYSE:CL)

apricus wealth LLC acquired a new position in Colgate-Palmolive (NYSE:CL) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,540 shares of the company’s stock, valued at approximately $264,000.

A number of other large investors also recently modified their holdings of the stock. Mcdaniel Terry & Co. bought a new position in shares of Colgate-Palmolive during the third quarter valued at about $201,000. Assenagon Asset Management S.A. lifted its position in shares of Colgate-Palmolive by 124.9% during the 3rd quarter. Assenagon Asset Management S.A. now owns 437,863 shares of the company’s stock worth $45,455,000 after buying an additional 243,185 shares in the last quarter. IFM Investors Pty Ltd lifted its position in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. IFM Investors Pty Ltd now owns 169,699 shares of the company’s stock worth $17,616,000 after buying an additional 6,330 shares in the last quarter. Commonwealth Financial Services LLC boosted its stake in shares of Colgate-Palmolive by 12.3% in the 3rd quarter. Commonwealth Financial Services LLC now owns 2,598 shares of the company’s stock worth $266,000 after buying an additional 285 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its holdings in shares of Colgate-Palmolive by 4.2% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 20,975 shares of the company’s stock valued at $2,177,000 after acquiring an additional 851 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now owns 5,146 shares of the company’s stock, valued at $529,729.24. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 over the last ninety days. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 0.8 %

Shares of Colgate-Palmolive stock opened at $99.75 on Friday. The company’s 50-day moving average price is $103.31 and its 200-day moving average price is $97.84. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 12-month low of $71.46 and a 12-month high of $109.30. The company has a market cap of $81.84 billion, a price-to-earnings ratio of 31.57, a PEG ratio of 3.54 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 EPS. On average, equities analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.01%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Wall Street Analyst Weigh In

CL has been the topic of several research analyst reports. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Evercore ISI increased their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $106.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.